The densities of stromal immune cells, including eTh cells, eCTL, and eTAM, as well as tumor PD-L1 expression, were also comparable between tumors with or without ALK rearrangement (Figure 3I, Supplementary Table S2). The gene discussed is ALK; the disease is neoplasm.